| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
  鹅麟依旧≈ 扫地僧 ............duitKWSPkita fully support KOTRA.... Target Price RM2.30, duration 1.5 years Happy trading! 18/06/2014 18:41  logitrader http://www.klse.my/financial/quarterResult/YoY/quarter/0002/30-Sep-2014.jsp 27/11/2014 11:21 logitrader http://www.klse.my/financial/quarterResult/YoY/quarter/0002/31-Dec-2014.jsp 16/02/2015 17:34 averose 2QFY17 net profit soared more than nine times to RM5.8 mln, from RM591, 000 last year, attributed to higher export sales. Quarterly revenue also increased 14.6% Y.o.Y to RM45.1 mln, from RM39.3 mln in 2QFY16. 10/02/2017 10:28  Glaceau 'Kotra Pharma (M) Sdn Bhd, are also recognized as the leading companies in the global halal nutraceuticals & vaccines market' https://www.medgadget.com/2017/09/halal-nutraceuticals-vaccines-market-is-anticipated-to-register-7-7-cagr-through-2016-2026.html 13/10/2017 04:39 Glaceau The Board of Directors of KOTRA wishes to announce that the Board of Directors has resolved to recommend a single tier final dividend of 2 sen net per ordinary share for the financial year ended 30 June 2017, subject to the approval of the shareholders at the forthcoming 18th Annual General Meeting of the Company. The proposed final dividend if approved, the Entitlement Date and Date of Payment will be fixed on 3 January 2018 and 18 January 2018 respectively. This announcement is dated 12 October 2017. 13/10/2017 04:46 tecpower http://www.straitstimes.com/business/companies-markets/worst-southeast-asian-stock-market-may-be-buoyed-by-najib-budget 16/10/2017 09:04 BlackWhite Tecpower , ironically our stock market free fall shortly after the big B. ASEAN climbed. 25/11/2017 10:26 Glaceau Kotra's marketing effort. https://www.thestar.com.my/metro/metro-news/2017/11/22/repackaging-it-right-to-drive-ambitions-vitamin-c-range-packs-feature-new-elements-aimed-at-inspirin/ 05/12/2017 09:09  | FEATURED EVENT
 312 373 527 641 ActiveGainersLosers
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
